What is Pyxis Oncology, Inc. Common Stock's Market Cap?

Pyxis Oncology, Inc. Common Stock's Market Cap is $324.5M, based on as-reported figures from SEC (XBRL) filings.

What is Pyxis Oncology, Inc. Common Stock's Enterprise Value?

Pyxis Oncology, Inc. Common Stock's Enterprise Value is $291.5M, based on as-reported figures from SEC (XBRL) filings.

What is Pyxis Oncology, Inc. Common Stock's Price / Sales?

Pyxis Oncology, Inc. Common Stock's Price / Sales is 23.4×, based on as-reported figures from SEC (XBRL) filings.

What is Pyxis Oncology, Inc. Common Stock's EV / Revenue?

Pyxis Oncology, Inc. Common Stock's EV / Revenue is 21.0×, based on as-reported figures from SEC (XBRL) filings.

What is Pyxis Oncology, Inc. Common Stock's EV / EBITDA?

Pyxis Oncology, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Pyxis Oncology, Inc. Common Stock's Revenue (TTM)?

Pyxis Oncology, Inc. Common Stock's Revenue (TTM) is $13.9M, based on as-reported figures from SEC (XBRL) filings.

What is Pyxis Oncology, Inc. Common Stock's Net Income (TTM)?

Pyxis Oncology, Inc. Common Stock's Net Income (TTM) is -$88.7M, based on as-reported figures from SEC (XBRL) filings.

What is Pyxis Oncology, Inc. Common Stock's EBITDA?

Pyxis Oncology, Inc. Common Stock's EBITDA is -$87.9M, based on as-reported figures from SEC (XBRL) filings.

What is Pyxis Oncology, Inc. Common Stock's Diluted EPS (TTM)?

Pyxis Oncology, Inc. Common Stock's Diluted EPS (TTM) is -1.06, based on as-reported figures from SEC (XBRL) filings.

What is Pyxis Oncology, Inc. Common Stock's EBITDA Margin?

Pyxis Oncology, Inc. Common Stock's EBITDA Margin is -634.4%, based on as-reported figures from SEC (XBRL) filings.

Pyxis Oncology, Inc. Common Stock (PYXS) Financial Statements

Pyxis Oncology, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00PQFFCW4

XNAS · usd

3.89▲ 0.00 (0.00%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close3.89

Day's Range3.85 – 4.15

52-Week Range1.03 – 5.55

Volume1.2M

Avg Volume1.3M

Share Statistics

Shares Outstanding

Employees56

ExchangeXNAS

Listed2021-10-08

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Pyxis Oncology, Inc. Common Stock (PYXS)

What is Pyxis Oncology, Inc. Common Stock's Market Cap?: Pyxis Oncology, Inc. Common Stock's Market Cap is $324.5M, based on as-reported figures from SEC (XBRL) filings.
What is Pyxis Oncology, Inc. Common Stock's Enterprise Value?: Pyxis Oncology, Inc. Common Stock's Enterprise Value is $291.5M, based on as-reported figures from SEC (XBRL) filings.
What is Pyxis Oncology, Inc. Common Stock's Price / Sales?: Pyxis Oncology, Inc. Common Stock's Price / Sales is 23.4×, based on as-reported figures from SEC (XBRL) filings.
What is Pyxis Oncology, Inc. Common Stock's EV / Revenue?: Pyxis Oncology, Inc. Common Stock's EV / Revenue is 21.0×, based on as-reported figures from SEC (XBRL) filings.
What is Pyxis Oncology, Inc. Common Stock's EV / EBITDA?: Pyxis Oncology, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Pyxis Oncology, Inc. Common Stock's Revenue (TTM)?: Pyxis Oncology, Inc. Common Stock's Revenue (TTM) is $13.9M, based on as-reported figures from SEC (XBRL) filings.
What is Pyxis Oncology, Inc. Common Stock's Net Income (TTM)?: Pyxis Oncology, Inc. Common Stock's Net Income (TTM) is -$88.7M, based on as-reported figures from SEC (XBRL) filings.
What is Pyxis Oncology, Inc. Common Stock's EBITDA?: Pyxis Oncology, Inc. Common Stock's EBITDA is -$87.9M, based on as-reported figures from SEC (XBRL) filings.
What is Pyxis Oncology, Inc. Common Stock's Diluted EPS (TTM)?: Pyxis Oncology, Inc. Common Stock's Diluted EPS (TTM) is -1.06, based on as-reported figures from SEC (XBRL) filings.
What is Pyxis Oncology, Inc. Common Stock's EBITDA Margin?: Pyxis Oncology, Inc. Common Stock's EBITDA Margin is -634.4%, based on as-reported figures from SEC (XBRL) filings.